On September 15, 2020, the number of FSUE Moscow Endocrine Plant- ENDOPHARM personnel was 1800 people. The increase in the number of employees in comparison with 2019 is more than 65%,” said Karina Vigul, Deputy General Director for Human Resources and Administrative Affairs.
The growth in the number of personnel is due to the dynamic development of the Enterprise.
After reconstruction in January 2020 a workshop for the production of injectable medicines was opened, in which became possible to double the production capacity of liquid injectable medicines in vials, up to 40 million units per year, and also to organize production in new forms of release - in pre-filled syringes with a capacity of 30 million units per year, and lyophilized preparations in glass bottles with a capacity of 6.5 million units per year.
In the second quarter of 2020, the Pochep branch of the FSUE Moscow Endocrine Plant organized the production of high-quality domestic full-cycle disposable medical masks with a capacity of up to 4 million masks per day. Also, the Pochep branch has launched the release of the Dezenda sanitizer in bottles for individual use in the form of a spray containing 70% (by mass) isopropyl alcohol and glycerin as an active component, which helps moisturize the hands' skin.
The dynamic development of the Enterprise is due to the high requirements for the efficiency of production processes and staff qualifications. To maintain leadership positions in its field of activity, FSUE Moscow Endocrine Plant cooperates with 15 leading field-oriented educational organizations, whose students every year undertake practical training and carry out certification work at the Enterprise.
Since the beginning of 2020, students of Sechenov University, Moscow Polytechnic University, D. Mendeleyev University of Chemical Technology of Russia, NRU MGSU have successfully mastered the industrial practice program in the subdivisions of the FSUE Moscow Endocrine Plant, including using remote technologies to prevent the threat of spreading a new coronavirus infection. More than 40 students are studying at the leading universities of the country under the program of employer-sponsored education from the Enterprise, which together ensures the influx of young initiative and professional personnel in all areas of the Enterprise's activities.
The Enterprise gives special attention to the establishment of long-term cooperation with educational organizations of the Bryansk region. In 2023, a large-scale investment project will be implemented to organize the production of active pharmaceutical ingredients at the Pochep branch of the FSUE Moscow Endocrine Plant, which will create several hundred new high-tech job spaces. To provide production with highly qualified personnel by 2023, the Enterprise has organized work to recruit applicants for the Bryansk region for the employer-sponsored education program. The issue of organizing cooperation with many professional educational organizations and educational institutions of higher education of the Bryansk region in the field of training highly qualified personnel for production, scientific and agricultural divisions of the Pochep branch is under resolution.
The personnel component is the basis of the Enterprise's entire management policy. The corporate culture is based on openness and mutual respect. Moscow Endocrine Plant has created unique conditions for the effective implementation of the qualification potential and development of each employee.
Comment type is not specified in the component properties.